Trial Profile
A Trial to Evaluate Effect of Presatovir (Gs-5806)on the Qt/Qtc Interval in Healthy Adults
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Apr 2016
Price :
$35
*
At a glance
- Drugs Presatovir (Primary) ; Moxifloxacin
- Indications Respiratory syncytial virus infections
- Focus Adverse reactions; Pharmacokinetics
- 19 Apr 2016 New trial record
- 12 Mar 2016 Results presented at the 117th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics